These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12777209)

  • 61. Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate.
    Krieg M; Nass R; Tunn S
    J Clin Endocrinol Metab; 1993 Aug; 77(2):375-81. PubMed ID: 7688377
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Fluorescence detection of photosensitizer photoditazin in the tissue of benign prostatic hyperplasia].
    Iagudaev DM; Bulgakova NN; Sorokatyĭ AE; Geĭnits AV; Markova MV; Martov AG
    Urologiia; 2006; (2):20-3. PubMed ID: 16708584
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ectopic expression of FGF-3 results in abnormal prostate and Wolffian duct development.
    Chua SS; Ma ZQ; Gong L; Lin SH; DeMayo FJ; Tsai SY
    Oncogene; 2002 Mar; 21(12):1899-908. PubMed ID: 11896623
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cytoskeletal and cytocontractile protein composition of stromal tissue in normal, hyperplastic, and neoplastic human prostate. An immunocytochemical study with monoclonal antibodies.
    Castellucci E; Prayer-Galetti T; Roelofs M; Pampinella F; Faggian L; Gardiman M; Pagano F; Sartore S
    Ann N Y Acad Sci; 1996 Apr; 784():496-508. PubMed ID: 8651605
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Expression of androgen, oestrogen alpha and beta, and progesterone receptors in the canine prostate: differences between normal, inflamed, hyperplastic and neoplastic glands.
    Gallardo F; Mogas T; Baró T; Rabanal R; Morote J; Abal M; Reventós J; Lloreta J
    J Comp Pathol; 2007 Jan; 136(1):1-8. PubMed ID: 17078963
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Coexistence of atrial natriuretic factor (ANF) and oxytocin in neurons of the rat hypothalamus.
    Jirikowski GF; Back H; Forssmann WG; Stumpf WE
    Neuropeptides; 1986 Oct; 8(3):243-9. PubMed ID: 2946977
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Claudin-1 immunohistochemistry for distinguishing malignant from benign epithelial lesions of prostate.
    Krajewska M; Olson AH; Mercola D; Reed JC; Krajewski S
    Prostate; 2007 Jun; 67(9):907-10. PubMed ID: 17440968
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Stereology, a new morphological method of study prostatic function and disease.
    Bartsch G; Frick J; Rohr HP
    Prog Clin Biol Res; 1976; 6():123-41. PubMed ID: 66686
    [No Abstract]   [Full Text] [Related]  

  • 69. Basement membranes in fetal, adult normal, hyperplastic and neoplastic human prostate.
    Bonkhoff H; Wernert N; Dhom G; Remberger K
    Virchows Arch A Pathol Anat Histopathol; 1991; 418(5):375-81. PubMed ID: 2035251
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of alpha(1)-adrenoceptor (alpha(1)-AR) antagonists on cell proliferation and apoptosis in the prostate: therapeutic implications in prostatic disease.
    Kyprianou N; Chon J; Benning CM
    Prostate Suppl; 2000; 9():42-6. PubMed ID: 11056502
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tissue microenvironment and benign prostatic hyperplasia.
    Wei X; Xin L
    Aging (Albany NY); 2019 Jun; 11(11):3414-3415. PubMed ID: 31195369
    [No Abstract]   [Full Text] [Related]  

  • 72. Somatostatin receptors in prostate tissues and derived cell cultures, and the in vitro growth inhibitory effect of BIM-23014 analog.
    Tatoud R; Degeorges A; Prévost G; Hoepffner JL; Gauvillé C; Millot G; Thomas F; Calvo F
    Mol Cell Endocrinol; 1995 Sep; 113(2):195-204. PubMed ID: 8674827
    [TBL] [Abstract][Full Text] [Related]  

  • 73. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.
    Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M
    Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Estrogen receptor beta expression in human prostate tissue.
    Pasquali D; Staibano S; Prezioso D; Franco R; Esposito D; Notaro A; De Rosa G; Bellastella A; Sinisi AA
    Mol Cell Endocrinol; 2001 Jun; 178(1-2):47-50. PubMed ID: 11403893
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Characterization of corpora amylacea glycoconjugates in normal and hyperplastic glands of human prostate.
    Morales E; Polo LA; Pastor LM; Santamaría L; Calvo A; Zuasti A; Ferrer C
    J Mol Histol; 2005 May; 36(4):235-42. PubMed ID: 16200455
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Testosterone metabolism in superfused human hyperplastic prostate.
    Beastall GH
    Biochem Soc Trans; 1975; 3(5):677-80. PubMed ID: 1193265
    [No Abstract]   [Full Text] [Related]  

  • 77. [Pathological findings of the prostate and their consequences: a critical view].
    Dhom G
    Verh Dtsch Ges Pathol; 1993; 77():70-2. PubMed ID: 7511305
    [No Abstract]   [Full Text] [Related]  

  • 78. Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia.
    Wang W; Zhang X; Mize GJ; Takayama TK
    Prostate; 2008 Jul; 68(10):1064-75. PubMed ID: 18386288
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Distribution and concentration of zinc in the subcellular fractions of benign hyperplastic and malignant neoplastic human prostate.
    Dhar NK; Goel TC; Dube PC; Chowdhury AR; Kar AB
    Exp Mol Pathol; 1973 Oct; 19(2):139-42. PubMed ID: 4127820
    [No Abstract]   [Full Text] [Related]  

  • 80. [Reciprocal epithelio-stromal interactions in normal and neoplastic prostate].
    Amălinei C
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(2):391-8. PubMed ID: 17802951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.